Skip to NavigationSkip to content

News

Covaxin, developed by Bharat Biotech, will begin testing for the treatment of the novel coronavirus in humans from July.
The FDA has awarded marketing authorisation in the US to Roche’s Phesgo, a combination of subcutaneously injected Herceptin (trastuzumab) with...
A new strain of flu has emerged in pigs in China, with scientists warning it has pandemic potential.
Featuring focuses on the importance of pharmaceutical sustainability and the economics of the revolutionary but deeply expensive CAR T cancer therapy...
Gilead has announced that it will charge $2,340 for a 5 day treatment course of remdesivir, a drug that has been proven to reduce the symptoms of...
Drug watchdog NICE has chosen to stick with its earlier decision not to recommend Janssen’s Zytiga, combined with prednisone/prednisolone plus...
The FDA has moved to reject Allergan’s vascular endothelial growth factor (VEGF) factor A inhibitor, Abicipar pegol, as treatment for the eye...
Vaxart has announced the selection of its lead vaccine candidate for COVID-19 by Operation Warp Speed, a programme to find a vaccine for the US by...
China’s military have received approval to use a new vaccine candidate for coronavirus after clinical trials proved it was safe and showed some...
Pfizer has filed a lawsuit against the US government to allow it to directly help with the copayments of Medicare recipients for the company’s...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches